+110.7%
MCK vs CHTR
-65.7%
+176.4%
-27.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CHTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | +3.7% | -3.6% | -0.1% |
| 7D | -2.9% | -4.1% | +1.2% | -2.7% |
| 30D | +0.4% | -3.0% | +3.4% | +0.5% |
| 3M | +12.1% | +4.8% | +7.3% | +11.7% |
| 6M | -5.4% | -35.0% | +29.6% | -4.4% |
| YTD | +7.8% | -30.2% | +38.0% | +8.6% |
| 1Y | +22.9% | -44.8% | +67.7% | +25.0% |
| 3Y | +110.7% | -66.6% | +177.3% | +119.2% |
| All | +110.7% | -65.7% | +176.4% | +119.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CHTR.
Daily Out/Under-Performance
Portfolio return minus CHTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CHTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling